Credits: Health and me
For decades, Parkinson's disease has long been thought of as a brain disorder, characterized by the degeneration of dopamine-producing neurons in the substantia nigra — a region of the brain that regulates movement. The loss of these neurons progressively contributes to hallmark symptoms such as tremors, rigidity, and decreased movement. But groundbreaking new research appearing in the journal Nature Neuroscience is refuting that long-standing assumption. The roots of Parkinson's may not be in the brain at all, according to scientists from Wuhan University in China — they could be in the kidneys.
The new study, by a Wuhan University team in China, focuses on alpha-synuclein (α-Syn), a protein intimately associated with Parkinson's. Under normal conditions, α-Syn is involved in healthy neural function. But when it misfolds and aggregates, it becomes toxic and clumps together into Lewy bodies—Parkinson's and other related disease hallmarks.
This unexpected finding is based on an increasing amount of evidence that Parkinson's could start in peripheral organs and spread to the brain, as opposed to starting in the brain itself. The potential ramifications for early treatment, prevention, and detection are staggering.
According to the authors of the study, "We show that the kidney is a peripheral organ that is an origin of pathological α-Syn." Central to this research is a protein called alpha-synuclein (α-Syn) — already far and away with links to Parkinson's disease and other neurological disorders. In health, this protein is used in neuron function. But when it goes awry, it forms sticky clumps known as Lewy bodies, which disrupt brain function and are a hallmark of Parkinson's and dementia with Lewy bodies.
To reach their conclusion, the team performed a succession of very careful experiments. They studied kidney samples from individuals with Parkinson's and associated Lewy body dementias, as well as patients with chronic kidney disease (CKD) with no neurological symptoms. The results were dramatic: abnormal α-Syn growth was identified in the kidneys of 10 out of 11 individuals with Parkinson's or Lewy body dementia, and in 17 out of 20 CKD patients—even though these CKD patients had no evidence of disease in the brain during life.
What they discovered was astounding: Abnormal α-Syn deposits were found in 10 out of 11 Parkinson's or related disorder patients. But even more astonishing, 17 out of 20 CKD patients — with no known brain disorder — also exhibited early evidence of the same misfolded proteins in their kidneys.
This implies that protein clumping could start in the kidneys, many years before symptoms of neurological harm become evident. Traces of α-Syn pathology were also detected in regions of the brainstem and spinal cord in a few instances, again favoring the hypothesis of a kidney-to-brain route.
The kidneys are not passive waste filters; they also actively remove α-Syn from the bloodstream. When kidney function is impaired, as in chronic kidney disease, this elimination process is defeated. The consequence is the accumulation of toxic proteins within the kidneys, which migrate to the brain and ultimately trigger the damage cascade causing Parkinson's.
This shift in paradigm is strengthened by epidemiological data. Massive research has revealed that individuals with compromised kidney function are at considerably greater risk of getting Parkinson's disease. The correlation is nonlinear, with increasing steepness in the risk as kidney function worsens.
This link between kidneys and brain doesn't imply the brain isn't involved in Parkinson's, but it doesn't exclude other causes either. Indeed, past studies have indicated that the gut might also be a place where α-Syn is accumulated and transmitted to the brain early on. The new research indicates Parkinson's could be a multi-system disorder, initiated by a range of causes and mechanisms—such as the kidneys, the gut, and possibly even the heart.
As the authors of the study point out, "Removal of α-Syn from the blood may hinder the progression of Parkinson's disease, providing new strategies for therapeutic management of Lewy body diseases."
The revelation that the kidneys could have a central role in Parkinson's offers both new hope for early detection and intervention. If α-Syn accumulation in the kidneys can be identified before neurological signs are apparent, it might be an early warning sign, enabling the possibility of preventive measures or early treatment.
In addition, treatments to enhance kidney function or facilitate clearance of α-Syn from the bloodstream may prove to be useful weapons in the battle against Parkinson's and other disorders. This strategy would complement current methods, which target preservation of the brain's dopamine-neurons.
Although the research is revolutionary, it isn't without its constraints. The human tissue sample was quite small, and though mice work well as models for human biology, they are not replicas.
Even so, the evidence is compelling enough to support more research. Subsequent studies with bigger human populations, improved imaging technology, and more comprehensive genetic analysis could replicate and build on these findings.
If confirmed, the kidney-brain link might be the missing piece of the Parkinson's puzzle — setting the stage for earlier diagnosis, tailored treatments, and even preventive medicine aimed at flushing out or blocking α-Syn in the kidneys and blood.
The kidneys could be a silent trigger for Parkinson's disease, with poisonous protein accumulation moving from the kidneys into the brain. Keeping kidneys healthy might be the key in the battle against neurodegenerative disorders.
Credits: Canva
Every year, over one in 33 babies born in the United States, arrives with a birth defect, a leading cause of infant mortality. Although much of the risk is due to genes and unidentified environmental causes, a new Centers for Disease Control and Prevention (CDC) study identifies a number of modifiable risk factors that operate among most women under age 50. The findings, published in the American Journal of Preventive Medicine, emphasize targeted public health measures and individual lifestyle decisions in lowering the risk for major birth defects.
The CDC study examined data from 5,374 women between ages 12 and 49 who took part in the National Health and Nutrition Examination Survey between 2007 and 2020. Scientists zeroed in on five major risk factors that can be treated before or during pregnancy: obesity, diabetes, tobacco exposure, food insecurity, and low folate levels.
The findings were dramatic. Almost 66% of the interviewed women possessed at least one of these risk factors, and 10% possessed three or more. Obesity had impacted approximately one-third of women, and around five percent had diabetes. Almost 20% were exposed to tobacco smoking, vaping, or second-hand inhalation. Food insecurity, which impacts nutritional intake as well as access to prenatal vitamins, had affected around seven percent of women. Most alarming, 80 percent of women lacked folate, or vitamin B9, a key nutrient in fetal development.
Folate is also crucial to DNA synthesis, cell growth, and red blood cell production. During early pregnancy, lack of folate can interfere with neural tube formation, resulting in neural tube defects like spina bifida and anencephaly. The FDA has required folic acid fortification in enriched cereal-grain food since 1998, reducing the number of neural tube defects by an estimated 1,300 cases per year.
Even after fortification, the CDC study showed that almost eight out of ten women were still below the 400 micrograms (mcg) of folic acid per day, even after supplement use. Only 13% were at the recommended daily dose, leaving millions of women at increased risk of avoidable birth defects. Natural foods that are good sources of folate, like leafy green vegetables, legumes, asparagus, avocados, broccoli, and fortified cereals, are still imperative to a balanced diet.
Obesity and diabetes became prominent factors in high risk. Both conditions can disrupt metabolism of nutrients, such as folate, and increase the risk of congenital heart defects, neural tube defects, and orofacial malformations in the fetal fetus. Obesity occurs in one-third of women of childbearing age, and close to five percent have diabetes, which includes undiagnosed or uncontrolled diabetes.
Controlling these conditions with diet, physical activity, and blood sugar testing is an important part of preconception care. As the CDC's Dr. Wang said, "The risks can be reduced through measures such as taking the recommended 400 micrograms of folic acid every day, eating a good diet, exercise, and controlling blood sugar."
Both active and passive tobacco exposure causes the introduction of toxins that raise oxidative stress and compromise nutrient intake. Almost 20% of the women studied had raised serum cotinine levels, indicating tobacco exposure. Previous studies have associated maternal smoking with preterm delivery, birth weight, stillbirth, and Sudden Infant Death Syndrome (SIDS).
Food insecurity adds to these risks. Approximately seven percent of women indicated a severe problem in accessing healthy food. Malnutrition in the mother can lead to deficiencies in important nutrients, including folate, and can increase the risk of obesity or metabolic disease in the child as an adult. Restricted availability of prenatal supplements also adds to these risks, especially in low-income groups.
The CDC analysis also showed dramatic disparities. Although risk factors were less common among teens and young women in their early twenties, almost three-quarters of women 35 to 49 years old had at least one risk factor. Non-Hispanic Black women had the most burden, with 80% having at least one risk factor, followed by 62% of non-Hispanic White women. Economic status was another predictor, with lower-income women having more than one risk factor, such as food insecurity and low folate status.
These disparities point to the importance of targeted interventions, such as affordable nutrition programs, smoking cessation programs, and preconception counseling, especially in communities with systemic barriers to healthcare.
Although causes of the majority of birth defects continue to be multifactorial, researchers typically cite a combination of genetics, environmental exposures, and maternal health as the culprits. Approximately 25% of defects are caused by chromosomal or genetic anomalies, such as Down syndrome. Environmental conditions, such as infection, diabetes in the mother, inadequate nutrition, and particular medications, are responsible for approximately five to ten percent. The other 65% are thought to be caused by intricate or unexplained interactions between genetic risks and the environment.
Obesity, diabetes, smoking, and folate deficiency can interfere with vital biological processes, such as the one-carbon cycle, which utilizes nutrients such as folate, vitamin B12, and choline to control DNA synthesis and cell division. If this cycle does not work, the development of the brain and spinal cord in the fetus can be impaired.
Prevention is fundamental. Women preparing for pregnancy need to achieve a healthy weight, control blood sugar, not use tobacco, have regular intake of folic acid supplements, and eat well-balanced diet with high natural sources of folate. Public health initiatives that enhance access to healthy food and prenatal supplements are important, especially for women experiencing food insecurity.
Health care professionals are responsible for risk factor screening, preconception counseling, and informing women of salutary measures to maximize fetal health. Even small changes in lifestyle, i.e., better nutrition, regular physical exercise, and the use of folic acid supplements, can decrease significantly the risk of severe birth defects.
Birth defects occur in one of every 33 babies and are the cause of about 20% of infant mortality. They may be mild, like clubfoot or webbed feet, to life-threatening and severe, like anencephaly or Trisomy 13. Although genetics cannot be changed, the CDC report highlights that most women have modifiable risk factors that, when corrected, can reduce the risk of complications.
Dr. Wang stresses, "Every expecting family wishes for a healthy baby and healthy pregnancy. When families and their healthcare providers understand the modifiable risk factors for birth defects, they can make data-driven choices that may result in healthier babies and pregnancies."
Credits: Health and me
For nearly three decades, the Foodborne Diseases Active Surveillance Network—better known as FoodNet—has been a cornerstone of food safety monitoring in the United States. Established in the 1990s, the system actively tracked laboratory-confirmed cases of foodborne infections across 10 states, covering more than 50 million Americans. It was widely regarded as the most reliable source of data on how foodborne pathogens affect people in real time.
But in July, the Centers for Disease Control and Prevention (CDC) made a dramatic change that caught even public health experts off guard. FoodNet, which once monitored eight of the most common foodborne pathogens, will now actively track only two: Salmonella and Shiga toxin-producing E. coli (STEC). Monitoring of the other six pathogens—Campylobacter, Cyclospora, Listeria, Shigella, Vibrio, and Yersinia—has been cut from the system’s required surveillance.
The CDC has defended the move as a resource-driven necessity, but food safety officials warn the implications could be far-reaching.
The CDC has stated that the decision was rooted in funding limitations. In a memo shared with the Connecticut Department of Health, the agency wrote: “Funding has not kept pace with the resources required to maintain the continuation of FoodNet surveillance for all eight pathogens.”
CDC spokesperson Paul Prince echoed this sentiment in a statement, narrowing surveillance would allow FoodNet staff “to prioritize core activities” and “steward resources effectively.”
The backdrop of the decision is years of budgetary tightening. Under the Trump administration, the CDC and other federal agencies faced significant cuts, with the CDC losing hundreds of employees in a single year. While the agency still maintains other surveillance programs—including the National Notifiable Diseases Surveillance System and the Listeria Initiative—those systems are passive. Unlike FoodNet, which actively gathered case information from hospitals and laboratories, passive systems depend on health departments voluntarily reporting infections.
FoodNet was unique in its reach and approach. Operating in 10 states—Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and select counties in California and New York—the program didn’t simply count cases. It collected detailed data about each infection, including patient demographics, hospitalization rates, and outcomes. This level of detail allowed scientists to track trends, spot outbreaks early, and identify which foods posed the greatest risks.
With six pathogens now off the mandatory list, experts worry the CDC is losing its clearest lens into the country’s food safety picture.
“FoodNet doesn’t just count cases,” explained Carlota Medus, who supervises the Minnesota Department of Health’s foodborne diseases unit. “The FoodNet sites collect robust data that contribute to the understanding of certain infections. Without that, we’ll miss trends and lose the ability to compare data over time.”
Salmonella and STEC are among the leading causes of severe foodborne illness, accounting for significant numbers of hospitalizations and deaths each year. But the other six pathogens removed from FoodNet’s core surveillance aren’t minor players.
By removing active surveillance of these pathogens, public health agencies may not immediately detect upticks in infections—or worse, may not realize when an outbreak is underway until it spreads widely.
Foodborne infections are legally reportable in the U.S., but passive reporting systems depend heavily on overwhelmed local health departments. Without the active case-finding that FoodNet provided, some infections may never be logged.
This shift doesn’t just risk slower outbreak detection; it also undermines years of carefully built datasets. Tracking trends over time requires consistency. If monitoring drops for certain pathogens, comparing future case numbers to historical data becomes nearly impossible.
Medus warned that “long term, it will affect our ability to use surveillance data to better understand risks in the food supply.” That data, she noted, has historically been critical in shaping both state and federal food safety policies.
The White House has insisted that food safety remains a top priority. A spokesperson for the administration said in a statement: “The health and safety of the American people is the Administration’s utmost priority. USDA, HHS, FDA, and the CDC will continue to cooperate and maintain the highest vigilance to safeguard our food supply against pathogens.”
Still, the quiet rollout of the change with no public announcement until uncovered by NBC News—has left many food safety experts uneasy. Transparency is key in public health, and the perception of cuts without clear communication erodes public trust.
For the average consumer, the change won’t alter day-to-day food safety advice. Washing produce, cooking meat to safe temperatures, avoiding unpasteurized dairy, and practicing good kitchen hygiene remain the best defenses against foodborne illness.
But behind the scenes, fewer eyes on potential threats may mean outbreaks are detected later and policy shifts are slower to emerge. The U.S. already sees an estimated 48 million cases of foodborne illness each year, leading to 128,000 hospitalizations and 3,000 deaths, according to the CDC. Without robust surveillance, those numbers could be harder to track—or worse, to reduce.
The cut to FoodNet highlights a deeper issue, foodborne illness surveillance is underfunded despite being essential. Experts argue that instead of scaling back, the U.S. should be expanding monitoring to capture new and emerging pathogens, especially as globalization and climate change reshape the food supply.
For now, FoodNet’s infrastructure remains intact, and states are free to continue monitoring other pathogens on their own if they have the resources. But state health departments often rely on federal funding to support surveillance staff. Without it, few will be able to maintain the same level of vigilance.
(Credit-2024 World Medical Innovation forum/CDC)
The White House has fired the director of the US Centers for Disease Control and Prevention (CDC), Susan Monarez. The White House stated that Monarez was "not aligned with the president's agenda." Her firing has created a lot of controversy. Monarez's lawyers quickly responded, saying she was not told about her removal and would not quit her job. They accused Health Secretary Robert F. Kennedy Jr. of targeting her because she refused to approve "unscientific, reckless directives." They also claimed Kennedy was "weaponizing public health."
Monarez is a scientist who specializes in infectious disease research. President Donald Trump nominated her, and she was confirmed by the Senate in July. She was the first CDC director in 50 years to not have a medical degree
On the same day Monarez was fired, the Food and Drug Administration (FDA) approved new COVID-19 vaccines but with strict rules about who can get them. The vaccines will be available for all seniors, but not for younger adults and children who do not have other health problems. Health Secretary Kennedy commented on this, saying that the broad vaccine rules from the previous administration have now been "rescinded," or taken back.
Monarez's firing is just one part of the problems at the CDC. Earlier this month, a union for CDC employees announced that about 600 workers had been fired. The people who lost their jobs worked on important topics like infectious diseases and environmental hazards. In addition, Monarez had recently been comforting staff after a gunman, who believed he was harmed by COVID-19 vaccines, attacked the CDC headquarters and killed a police officer.
There have also been reports that the Trump administration might get rid of COVID-19 vaccines completely. Health Secretary Kennedy, who is well-known for being skeptical of vaccines, has already made a big move by pulling $500 million in federal funding from 22 projects that were developing new mRNA vaccines. He said these vaccines don't work well against respiratory infections. However, medical experts say his claims are false and that his actions could make people lose trust in science.
HHS has also announced a big change in how it invests in vaccine research. The department is moving away from funding mRNA vaccine projects and is instead focusing on what it calls "alternative" vaccine technologies. This shift has drawn criticism from scientists who say that mRNA technology was crucial to the rapid COVID-19 response and is a vital tool for fighting future pandemics.
Another major change was when Kennedy got rid of every member of the Advisory Committee on Immunization Practices (ACIP). This group had been advising the CDC for decades. Kennedy replaced them with a small, hand-picked group, claiming the old members had conflicts of interest. These changes have made many medical professionals confused and concerned. Some clinics and pharmacies are now unsure whether to offer certain vaccines to pregnant women or healthy children, and they don't know if insurance will cover them. While older people and those with health problems can still get vaccines, access has become less clear for healthy children and adults.
© 2024 Bennett, Coleman & Company Limited